Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and infection

about

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and infection

Item

http://www.wikidata.org/entity/Q57301725

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Therapeutic efficacy of amoxic ...... erial overgrowth and infection

@en

Therapeutic efficacy of amoxic ...... erial overgrowth and infection

@nl

type

Item

label

Therapeutic efficacy of amoxic ...... erial overgrowth and infection

@en

Therapeutic efficacy of amoxic ...... erial overgrowth and infection

@nl

prefLabel

Therapeutic efficacy of amoxic ...... erial overgrowth and infection

@en

Therapeutic efficacy of amoxic ...... erial overgrowth and infection

@nl

P1476

Therapeutic efficacy of amoxic ...... erial overgrowth and infection

@en

P2093

Aleksandra Kaczka

http://www.w3.org/2001/XMLSchema#string

Anita Gąsiorowska

http://www.w3.org/2001/XMLSchema#string

Cezary Chojnacki

http://www.w3.org/2001/XMLSchema#string

Cezary Rudnicki

http://www.w3.org/2001/XMLSchema#string

Jan Chojnacki

http://www.w3.org/2001/XMLSchema#string

Paulina Konrad

http://www.w3.org/2001/XMLSchema#string

P2860

Kyoto global consensus report on Helicobacter pylori gastritis

Second and third line treatment options for Helicobacter pylori eradication

The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease

What are the effects of proton pump inhibitors on the small intestine?

Microbiota and SCFA in lean and overweight healthy subjects

Small intestinal bacterial overgrowth: diagnosis and treatment.

Effects of long-term PPI treatment on producing bowel symptoms and SIBO.

Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.

The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis

Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.

P304

213-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/PG.2018.74228

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30302165

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

small intestinal bacterial overgrowth

P932

6173078

http://www.w3.org/2001/XMLSchema#string